494
Participants
Start Date
May 31, 2006
Study Completion Date
April 30, 2007
Quetiapine
Amitriptyline
Bupropion
Citalopram
Duloxetine
Escitalopram
Fluoxetine
Paroxetine
Sertraline
Venlafaxine
Research Site, Everton Park
Research Site, Southport
Research Site, Frankston
Research Site, Malvern
Research Site, Prahran
Research Site, Richmond
Research Site, Brisbane
Research Site, Assebroek
Research Site, Brussels
Research Site, Ghent
Research Site, Kortrijk
Research Site, Liège
Research Site, Mechelen
Research Site, Tielt
Research Site, Edmonton
Research Site, Moncton
Research Site, Mount Pearl
Research Site, St. John's
Research Site, Halifax
Research Site, Toronto
Research Site, Pointe-Claire
Research Site, Brno
Research Site, Havířov
Research Site, Havlíčkův Brod
Research Site, Nové Město nad Metují
Research Site, Olomouc
Research Site, Ostrava
Research Site, Prague
Research Site, Helsinki
Research Site, Järvenpää
Research Site, Salo
Research Site, Turku
Research Site, Angoulême
Research Site, Arcachon
Research Site, Caen
Research Site, Château-Gontier
Research Site, Élancourt
Research Site, Le Pecq
Research Site, Nîmes
Research Site, Paris
Research Site, Rennes
Research Site, Toulouse
Research Site, Augsburg
Research Site, Berlin
Research Site, Cologne
Research Site, Münster
Research Site, Bergen
Research Site, Flekkefjord
Research Site, Fyllingsdalen
Research Site, Hamar
Research Site, Lysaker
Research Site, Oslo
Research Site, Skien
Research Site, Gdansk
Research Site, Lodz
Research Site, Nowy Targ
Research Site, Szczecin
Research Site, Torun
Research Site, Warsaw
Research Site, Bucharest
Research Site, Piteşti
Research Site, Pretoria
Research Site, Durban
Research Site, Cape Town
Research Site, Falköping
Research Site, Gothenburg
Research Site, Halmstad
Research Site, Malmo
Research Site, Stockholm
Research Site, Sundsvall
Research Site, Trollhättan
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY